CTSO
Cytosorbents Crp
3.70$
-3.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -67.1% | -87.2% | -53.7% | -54.2% | -28.6% | -25.6% | -39.7% | -15.7% | -27.2% | -52.3% | -13.1% | -18.1% | -27.7% | |
| 6.0% | 10.8% | 4.9% | 5.0% | 5.0% | 4.7% | 4.6% | 4.6% | 4.2% | 4.2% | 4.2% | 3.9% | 4.1% | |
| 17.4% | 14.3% | 10.7% | 9.5% | 5.6% | 16.5% | 9.4% | 6.0% | 5.1% | 15.8% | 6.1% | 9.5% | 9.1% | |
| 2.2% | 1.0% | -18.6% | -31.3% | 14.8% | -16.6% | -4.4% | 13.1% | -7.7% | -12.6% | 14.2% | 29.6% | 5.9% | |
| 3.3% | 1.8% | 1.4% | 1.4% | 3.5% | 1.4% | 0.5% | 0.4% | 0.2% | 0.7% | 0.1% | 0.3% | 0.3% | |
| -3.3% | -1.8% | -1.4% | -1.3% | -3.5% | -1.4% | -0.5% | -1.4% | 0.6% | -3.2% | -0.5% | -0.4% | -0.9% | |
| – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 26.8% | – | – | – | |
| 8.4% | 166.2% | -6.4% | 111.2% | -1.1% | 1.8% | 78.3% | 0.0% | 0.0% | 26.8% | 0.0% | 0.0% | 6.7% | |
| -61.8% | 78.5% | -61.4% | -1.7% | -32.2% | -26.3% | 38.3% | -14.4% | -28.1% | -13.9% | -16.2% | -19.1% | -19.4% | |
| -70.5% | -89.0% | -55.1% | -55.6% | -32.0% | -27.0% | -40.2% | -16.1% | -27.3% | -52.9% | -13.2% | -18.4% | -28.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.